Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor
about
Residues of corticotropin releasing factor-binding protein (CRF-BP) that selectively abrogate binding to CRF but not to urocortin 1Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1Family-B G-protein-coupled receptorsA role for brain stress systems in addiction.CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndromeRole of urocortin in pregnancy: An update and future perspectivesEvidence for the role of corticotropin-releasing factor in major depressive disorderChronic and acute effects of stress on energy balance: are there appropriate animal models?Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptorsUrocortins: CRF's siblings and their potential role in anxiety, depression and alcohol drinking behavior.Functional Impact of Corticotropin-Releasing Factor Exposure on Tau Phosphorylation and Axon TransportNMR structural characterization of a minimal peptide antagonist bound to the extracellular domain of the corticotropin-releasing factor1 receptorStructure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligandTobacco addiction and the dysregulation of brain stress systems.Structural basis for hormone recognition by the Human CRFR2{alpha} G protein-coupled receptorUrocortin-deficient mice display normal stress-induced anxiety behavior and autonomic control but an impaired acoustic startle responseCorticotropin-releasing factor receptor 2 is a tonic suppressor of vascularizationLocal secretion of urocortin 1 promotes microvascular permeability during lipopolysaccharide-induced inflammationNeuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: Implications for balancing stress and affectUrocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptorsCorticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neuronsTopographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylaseAnorectic actions of prolactin-releasing peptide are mediated by corticotropin-releasing hormone receptorsDistribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibresCorticotropin-releasing factor receptor types 1 and 2 are differentially expressed in pre- and post-synaptic elements in the post-natal developing rat cerebellumIdentification of urocortin 3 afferent projection to the ventromedial nucleus of the hypothalamus in rat brain.Urocortin induces positive inotropic effect in rat heartUrocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasisCRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behaviorChronic peripheral administration of corticotropin-releasing factor causes colonic barrier dysfunction similar to psychological stressA novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart diseaseInvolvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.Stress-activated afferent inputs into the anterior parvicellular part of the paraventricular nucleus of the hypothalamus: Insights into urocortin 3 neuron activation.Alcohol-preferring rats show decreased corticotropin-releasing hormone-2 receptor expression and differences in HPA activation compared to alcohol-nonpreferring rats.Central urocortin 3 and type 2 corticotropin-releasing factor receptor in the regulation of energy homeostasis: critical involvement of the ventromedial hypothalamus.Type 2 corticotropin-releasing factor receptor in the ventromedial nucleus of hypothalamus is critical in regulating feeding and lipid metabolism in white adipose tissue.Injection of Urocortin 3 into the ventromedial hypothalamus modulates feeding, blood glucose levels, and hypothalamic POMC gene expression but not the HPA axis.Hypoactivation of CRF receptors, predominantly type 2, in the medial-posterior BNST is vital for adequate maternal behavior in lactating rats.Increased anxiety in corticotropin-releasing factor type 2 receptor-null mice requires recent acute stress exposure and is associated with dysregulated serotonergic activity in limbic brain areas.Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior
P2860
Q24308848-E523D8E1-15FA-4EF0-A022-C6B1CEC8FEBCQ24314090-C45FF83D-8AFC-4FB7-A749-32FFB061BECFQ24542556-2FE76473-4DDC-43C3-AA08-CD47AA7385C5Q24649537-8AD9A829-8F42-48D9-BE24-2C2F95841563Q24671910-9E694BC0-1BDD-4D6E-AA68-77DB255EF3D2Q26741521-C5C7099A-7AAC-472C-8E52-8F915B6C9DEBQ26798878-1B721B65-8E4B-4CD8-ABA2-DD1301900E79Q26823174-A2D29115-EFE6-427B-835F-CD9216667FABQ26851381-F582C439-B72F-438D-B0CF-CF75E1ECC142Q27011274-8C1701AA-6B40-4FE0-9F5B-0E0D24F20AD2Q27329404-9B797C13-A185-4F91-AF0C-7D18E73EBEAFQ27643440-9EFCF746-30D9-4FE9-A3AF-CF79C205060AQ27644056-1DC10299-5F40-4816-A161-849FA196483DQ28111988-BE6840DE-D314-4814-98AD-30BEEFC09A1BQ28296331-91CB71D6-460A-402E-AB28-FECAB7989B5DQ28507210-39FFE728-8962-465F-A114-290D6A9A24E3Q28511231-5E1B3FE4-2112-4D1B-8D52-4B2BDD4A2D5FQ28564845-CBBA3539-831D-4BC4-92B3-A173AECD1155Q28565572-E545BC75-8A77-4610-BF15-17179A55F511Q28567593-41108714-3DBF-4200-8140-B77486C01323Q28568495-2A055088-63FF-4747-A207-1BDBF48D0FB2Q28569531-B7B6B609-480F-4340-A41D-B2BBCA6A0D5BQ28570885-170DC25C-2ED4-4088-A784-C74432F169ACQ28573727-735E9A22-878E-489B-871B-CA7019704B1EQ28574355-AEF0530A-A747-4E0D-9B5C-75346ADF9B9FQ28574974-B1D99354-1B7B-4666-B121-34F362B1D747Q28577408-FB0BCB82-24AF-458F-86EE-66D59D046BA8Q28577670-282CFEE6-B486-4AF9-AEE4-02392A97055AQ28580222-30D81C8D-0A8B-4674-91EA-505307B186EAQ28580728-0DB39234-A93A-4EFD-955F-B0C40ACB57C9Q28588519-1283128D-5A46-456C-B95B-94214D29EC97Q30300188-85CB98DD-1297-466A-B2C1-5219E684A911Q30300356-F31EF7C7-FB2F-4210-9D56-136750539B1FQ30412859-47FF5211-576F-4038-A3B6-61B3C272166FQ30422882-7EB9B876-5DF1-4824-88A6-03F3DDC2A2A7Q30423107-AC1FFCCA-A633-4648-AD6F-3E9705AFFF4DQ30433300-A7AF240B-139F-4B1B-8BF0-1C78174FC28CQ30434209-EFF78733-977E-4EB0-A211-B69D1748F725Q30438084-BFFD3974-2164-4A1E-9E1D-CCD66A936469Q30448992-2889DB0D-40D2-44C7-A9D9-8C3B3046FC49
P2860
Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Identification of urocortin II ...... affinity for the CRF2 receptor
@ast
Identification of urocortin II ...... affinity for the CRF2 receptor
@en
Identification of urocortin II ...... affinity for the CRF2 receptor
@nl
type
label
Identification of urocortin II ...... affinity for the CRF2 receptor
@ast
Identification of urocortin II ...... affinity for the CRF2 receptor
@en
Identification of urocortin II ...... affinity for the CRF2 receptor
@nl
prefLabel
Identification of urocortin II ...... affinity for the CRF2 receptor
@ast
Identification of urocortin II ...... affinity for the CRF2 receptor
@en
Identification of urocortin II ...... affinity for the CRF2 receptor
@nl
P2093
P2860
P921
P3181
P356
P1476
Identification of urocortin II ...... affinity for the CRF2 receptor
@en
P2093
C Donaldson
K Kunitake
L Bilezikjian
M H Perrin
P2860
P304
P3181
P356
10.1073/PNAS.121165198
P407
P577
2001-06-19T00:00:00Z